ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Geriatric Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

11,590Medicare Part D Prescriptions Filled, Including Refills

Rank: 15 out of 103

$1.08M Total Retail Price of All Prescriptions

Rank: 4 out of 103

276 Patients Receiving at Least One Drug in Part D
32%Patients 65 Years and Older
86% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Michigan
Lower avg

Schedule Two
Controlled Substances

61% of this provider’s 276 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

43% of this provider’s 276 patients filled at least one prescription for a schedule three drug, compared to an average of 20%.

Risky Drugs to Seniors

1% of this provider’s 3,413 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

30% of this provider’s prescriptions were for brand-name drugs, compared to an average of 22%.

Prescription Price

$93 was the average price of a prescription from this provider, compared to $53 among peers.

Prescriptions per Patient

42 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Michigan
OXYCODONE HCL 860 137 S2 1 53
LISINOPRIL 487 157 2 2
HYDROCODONE-ACETAMINOPHEN 460 184 S3 3 3
AMLODIPINE BESYLATE 449 153 4 5
SIMVASTATIN 439 132 5 1
OMEPRAZOLE 370 81 6 7
BACLOFEN 294 45 7 69
OXYCONTIN 294 50 S2 7 119
PROAIR HFA 262 73 9 33
FLUTICASONE PROPIONATE 256 71 10 47
ADVAIR DISKUS 256 67 10 43
MORPHINE SULFATE ER 254 16 S2 12 63
SERTRALINE HCL 250 36 13 18
METOPROLOL SUCCINATE 206 58 14 17
GABAPENTIN 159 62 15 13
HYDROCHLOROTHIAZIDE 157 62 16 15
LEVOTHYROXINE SODIUM 140 59 17 4
VENTOLIN HFA 133 20 18 81
METHADONE HCL 126 16 S2 19 106
METOPROLOL TARTRATE 120 40 20 8
SPIRIVA 113 34 21 51
SINGULAIR 110 46 22 124
ZOLPIDEM TARTRATE 110 33 22 35
LYRICA 109 28 24 89
POTASSIUM CHLORIDE 108 33 25 12
ISOSORBIDE MONONITRATE ER 103 66 26 26
CYMBALTA 101 13 27 56
METFORMIN HCL 96 33 28 14
ATORVASTATIN CALCIUM 83 14 29 21
CLOPIDOGREL 79 61 30 28
TRAZODONE HCL 79 0 30 39
INSULIN SYRINGE 79 11 30 97
NAPROXEN 78 16 33 82
MIRTAZAPINE 76 20 34 24
FUROSEMIDE 73 29 35 6
LANTUS 72 11 36 29
CITALOPRAM HBR 70 13 37 10
CARVEDILOL 70 51 37 22
NEXIUM 68 37 39 78
PANTOPRAZOLE SODIUM 67 13 40 37
LOSARTAN POTASSIUM 67 43 40 23
LIDODERM 67 0 40 70
TAMSULOSIN HCL 66 49 43 30
OPANA ER 61 0 S2 44 243
MONTELUKAST SODIUM 61 22 44 205
IBUPROFEN 60 0 46 75
ATENOLOL 58 49 47 19
QUETIAPINE FUMARATE 57 0 48 46
MORPHINE SULFATE 57 0 S2 48 139
WARFARIN SODIUM 53 27 50 9
DOXAZOSIN MESYLATE 53 21 50 133
VYTORIN 51 51 52 183
RANITIDINE HCL 51 20 52 31
ACETAMINOPHEN-CODEINE 50 17 S3 54 52
TRICOR 50 29 54 147
ALLOPURINOL 50 26 54 36
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Sept. 28, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.